NUVAIRA

Nuvaira is a privately held company headquartered in Minneapolis, MN. The company's proprietary dNerva® Targeted Lung Denervation System addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma, with a one-time, outpatient bronchoscopic procedure designed to reduce the frequency and severity of COPD exacerbations. The dNerva® TLD system is CE Mark approved and is under clinical investigation and not commercially available in the USA. Nuvaira and dNerva are registered trademarks of Nuvaira, Inc.